Drug Pipeline

Ide-cel (bb2121) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06045806 A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide… Multiple Myeloma Active, Not Recruiting
Phase 2
NCT05393804 A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who… Multiple Myeloma Active, Not Recruiting
Not specified
NCT06357754 Transgene Assay Testing Service of Tumor Samples From Patients Who Received a… Non-Hodgkin Lymphoma Recruiting
Sponsors Running Ide-cel (bb2121) Trials
Memorial Sloan Kettering Cancer Center (1) Celgene (1) Bristol-Myers Squibb (1)
Disease Areas
Multiple Myeloma (3) Leukemia (1) Chronic Lymphocytic Leukemia (CLL) (1) Non-Hodgkin Lymphoma (1)
Get alerts when Ide-cel (bb2121) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free